SCHEMBL23699405

SCHEMBL23699405

CN(CC(Cc1ccccc1C#N)C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.41
PTPN1 P18031 1/20 0.38
CTSS P25774 9/20 0.38
CTSK P43235 7/20 0.38
CTSL P07711 2/20 0.37
CTSB P07858 2/20 0.37
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
FFAR1 O14842 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ADAMTS4 O75173 1/20 0.34
MMP13 P45452 1/20 0.34
DPP4 P27487 2/20 0.34
FAP Q12884 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23699386 0.82 CTSS (0.47) PTPN1CTSSCTSKSLC6A4
SCHEMBL1915404 0.82 PTPN1 (0.40) MAOBPTPN1CTSSCTSKCTSL
SCHEMBL1915409 0.82 PTPN1 (0.40) MAOBPTPN1CTSSCTSKCTSL
SCHEMBL23699429 0.81 CYP1A2 (0.51) SLC6A4
SCHEMBL25182312 0.81 MAOB (0.42) MAOBPTPN1CTSSCTSKCTSL
SCHEMBL23699431 0.80 MAOB (0.42) MAOBPTPN1CTSSCTSKCTSL
SCHEMBL23699440 0.79 FOLH1 (0.56) MAOBCTSSCTSKCTSLCTSB
SCHEMBL7382769 0.78 CYP1A2 (0.50) MAOBSLC6A2SLC6A4FFAR1DPP4
SCHEMBL23719091 0.75 CTSK (0.44) CTSSCTSKSLC6A4
SCHEMBL23699255 0.75 CTSK (0.44) CTSSCTSKSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed